Toggle navigation
BCMET
DATABASE
Augmented Breast Cancer
Metastasis Information
Home
POST-TRANSCRIPTIONAL MODIFICATION
MUTATION
PATHWAY
KEGG
REACTOME
GeneCards
NETWORKS
mRNA
miRNA
SMALL MOLECULES
OVERALL
ONCOPRINT
Expression analysis of mrnas
MYC amplification
CCND1 amplification
ERBB2 amplification
Expression analysis of ncrnas
mRNAs
miRNAs
lncRNAs
circRNAs
SURVIVAL BIOMARKERS
mRNA
CPE
KAI1 (CD82)
MEX3A
TRAF4
14-3-3Zeta (YWHAZ)
ACC1
ACKR4 and CCR7
ACTN1
AKT1
AKT2
AMACR
ARG2
ASAP1
ASB13
AXL
BACH1
BCL11A
BIRC5
BIRC5-1
BRCA1
BRCA2
BRM (SMARCA2)
BTNL9
CA13
CACNG4
CAV1
CBX7
CCL18
CCL5
CD155 (PVR)
CDCP1
CDH1
CDK14
CFL1
CPEB2
CTCF
CTSL
CXCL12
CXCL8 (IL8)
CXCR2
CXCR4
DAAM1
DCLK1
DDR2
DEK
DEPTOR
DFNA5 (GSDME)
DHRS2
DLL4 and JAG1-1
DLL4 and JAG1-2
DNAJB4 and CD81
DNAJB9
EF1-delta
EGFR
EVI1 (MECOM)
EZH2
FAM96A (CIAO2A) and FAM96B (CIAO2B)
FBXL10 (KDM2B)
FGF2
FGFR1
GAL1
GALNT8
GLI2
GPC3
GPX1
HIF1A
HOXD9
HULC
IGDQ
IGF2BP2
IL-39
IL32
IL6
IMP2 and IMP3
INSIG2
ITGA2
KIBRA (WWC1)
KIF17
KIF3C
LGR6
LOXL2
MAP7D1
MAP7D1-1
MAPK12
MDIG (RIOX2)
MET
MFAP5
MIF
MMP13
MMP2
MUC1
N4BP3
NFIC
NLRP3
NNMT
NOG
NPNT
NQO1 and PKLR
NRBE3 (PPP1R26)
NRG1
NUPR1
OPN (SPP1)
OR5B21
PAD1 (PSMD14)
PARD3
PCDH7
PDL1 (CD274)
PGC1A (PPARGC1A)
PIK3CA
PP1a
PRAME
PSAT1
PTBP1
PTHRP (PTHLH)
PTK2B
PYK2 (PTKB)
RACGAP1
RAD51
RANKL (TNFSF11) and RANK (TNFRSF11A)
RB1
RBBP8
RBP2
RFC3
RKIP
ROBO4
ROCK1
ROR-Gamma (RORC)
RUNX1
S100A4
SCAMP3
SCN4B
SCN5A
SEC14L3
SEZ6L2
SIRT5
SLIT2
SLUG (SNAI2)
SMC1A
SNAIL (SNAI1)
SOX2
SP2043
SPTBN1
SQSTM1/p62
SRP40 (SRSF5)
STAT3
STEAP1
STMN1
TFF1
TGFB1
TIPE2
TMEM126A
TP53
TRIM25
TRPV6
TWIST1
UBQLN1
VCAM-1
VEGF-C & VEGF-D
WASF3
WWP1
YAP
YB-1
YD0514
YTHDF3
YTHDF3-1
ZNF281
ZNF319
miRNA
miR-126
miR-23a
miR1910-3p
miRNA-29b
let-7 family
let-7a-5p
MicroRNA-206
MicroRNA-22
miR-101
miR-103
miR-105
miR-105 and miR-93- 3p
miR-10b
miR-124
miR-1246
miR-1269a
miR-1290
miR-1301
miR-130a
miR-132
miR-135b
miR-135b-5p
miR-138
miR-145
miR-146
miR-146a
miR-146a-1
miR-146a-2
miR-148a
miR-148b
miR-150
miR-154
miR-155
miR-155-5p
miR-181c
miR-185
miR-191 & miR-425
miR-1910-3p
miR-199a and miR-214
miR-19a, miR-93, miR-106
miR-200a
miR-200a, 200b and 200c, miR-141 and miR-429
miR-200b
miR-200c
miR-205
miR-206
miR-20b
miR-210
miR-211
miR-216b
miR-22
miR-223
miR-224
miR-23b/27b/24 Cluster
miR-26a
miR-27a
miR-27a-1
miR-29
miR-301a
miR-302
miR-30a
miR-31
miR-320a
miR-342-3p
miR-34a
mir-34a-1
miR-34a-5p
miR-34a-5p & miR-16-5p
miR-3614?5p
miR-367-3p, miR-548aq-5p, and miR-4710
miR-373
miR-374c-5p
miR-384
miR-411-5p
miR-421
miR-429
miR-4319
miR-455-3p
miR-520c
miR-542-3p
miR-5694
miR-629-3p
miR-7
miR-7- 5p
miR-7-5p
miR-760
miR-829b
miR-888
miR-9
miR-934
miR-96
miR-98
miR-98-5p
miR140-5p
Sal-like 4 - integrin -6-1
lncRNA
DANCR
EGOT
FGF14-AS2
HOTTIP
LINC01638
lincRNA-ROR
LOC554202
NCT0200088
ARNILA
ATB (IFITM3-216)
AU021063
BANCR
BCAR4
BHLHE40-AS1
BORG (CDC42EP5) /TRIM28
CASC2
CASC9
CCAT2
CERNA2
COX10-DT
CTD-210809.1
DGUOK-AS1
EZR-AS1
GAS5
GHET1
H19
HIF1A
HOST2
HOTAIR
HOXA11-AS
HULC
HUMT (LINC00857)
IRAIN
ITGB1
KISS1
LDB2
LINC BM (PINT)
Linc IN (LINC-PINT)
linc ZNF469-3
Linc-ITGB1-AS1
LINC00115
LINC00628
LINC00673 (LINC00511)
LINC00899
LINC00926
LINC00968
LINC01087
LINC01116
LINC01296 (DUXAP9)
LINC01638
LINC01787
LINC02273
LINP1
lncBCMA (TNFRSF17)
LncRNA PTH-AS
LncRNA T376626
LncRNA TRG-AS1
lncRNA-45
LOXL1-AS1
MACC1-AS1 and UCA1
MALAT1
MAYA (MNX1-AS1)
MIAT
NBAT1
NEAT1
NKILA
NNT-AS1
PVT1
RMST
ROR1
RUNX2
SKAI1BC
SNHG12
SNHG14
SNHG14-1
SNHG15
SNHG3
SPINT1-AS1
THY1-AS1 (RP11-334E6.12)
TP73-AS1
TTN-AS1
TUG1
UTUD6B-AS1 (PKD1L1-AS1)
VIM-AS1
XIST
ZEB1-AS1
ZEB2NAT
circRNA
AGFG1
CDYL
Cir-0089153
Circ-0061825 overexpression
Circ-UBR1
CircACAP2
circCCNB1, circSKA3
circDNMT1
circEHMT1
CircHIPK3
CircIRAK3
CircPTK2
CircRAD54L2
circRGPD6
circSCYL2
circSEPT9
HMCU
HOT1
Hsa_circ_0008673
hsa_circ_0068631
IRAK3, circ_0011946, KIF4A, circ_0052112, circ_000
MTDH/CASC3 regulated circ NOL10
NCAPG
ROBO1
SEPT9_i1
SMALL MOLECULES
1,3-dicaffeoylquicina
1,3-Dicaffeoylquinic acid
Aidiquining formula
Alternagin-C
Anesthetic propofol
Angiotensin II
Antrodia salmonea (medicinal mushroom)
autotaxin
Azacitidine
Baohuoside i in XIAOPI formula
BDMC-A, an analog of curcumin
benzo[a]pyrene
Bisdemethoxycurcumin (BDMC)
Cannabinoid receptors
Cathepsin c
Cathepsin D
Chemically synthesized LYRM03
Chemokine (C-C Motif) Ligand 2
Chinese medicine-TCM formula
Cimigenoside
Curcumin
Danirixin
Dihydroartemisinin
Disruptor of telomeric silencing 1-like (DOT1L)
DT-13
Estrone (postmenausal estrogen)
EW-7195
fenhexamid
Histone demethylase JARID1C
hnRNP (heterogenous nuclear ribonucleoprotein)A2/B1
Inositol Polyphosphate 5-Phosphatase PIPP
isoliquiritigenin
ketorolac
linolenic acid
Luteolin
maduramicin
Melatonin
Metformin
N6-methyladenosine
Nagin-c (2-1 integrin ligand)
Naringenin
nicotinamide-N-methyltransferase (NNMT)
Nobiletin
Opioids
Panax notoginseng saponins (PNS)
Parthenolide
ppGalNAc-T4
Pracinostat (SB939)
Pterostilbene
Pterostilbene-isothiocyanate
rivaroxaban and dabigatran
Salt-induced kinase-3 (SIK3)
Sanguinarine
Shikonin
Simvastatin
Sinomenine
sphingosine-1-phosphate
Su(var)3-9, Trithorax domain-containing 5
Suboptimal concentration of MEK inhibitor and FK506
thymoquinone
Tinagl1
Trolox
Walnut
Wenshen Zhuanggu formula
CCND1 amplification
EXPRESSION ANALYSIS
Based on Metastatic Breast Cancer (MET500 dataset)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)